Delivery Order SPE2DB22D2005-SPE2DB24FJHW6
Award Date 2/15/24
Potential Completion Date 3/8/24
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $5,624.62 for the supply of Tasigna 150 mg capsules. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare supplier for the U.S. Department of Defense. AmerisourceBergen, a large pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,624.62 firm fixed price delivery order is for the drug TASIGNA 200 MG CAPSULE 28S. The contract has an ultimate completion date of April 27, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,249.24 firm fixed-price delivery order is for the supply of Tasigna 200 mg capsules. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a comprehensive range of pharmaceutical and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product Tasigna 200 mg capsule. The order, valued at $5,624.62, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceuticals, medical supplies, and related distribution services in support of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $5,624.62, is for the supply of Tasigna 200 mg capsules. It is a firm fixed-price contract with an ultimate completion date of August 8, 2024. This award is not associated with any set-aside program. AmerisourceBergen, through its Corporate Office division, has been a significant supplier of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,624.62 delivery order contract is for the supply of Tasigna 200 mg capsules, a specialty medication. The contract has a firm fixed price and is scheduled to be completed by November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply 150 mg Tasigna capsules to the U.S. government. The contract, valued at $5,624.62, is a firm-fixed-price delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling of up to $999,999,999.00 through December 2025. This single-award IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tasigna 150 mg capsules. The contract is a Delivery Order valued at $16,873.86, with a firm fixed price and a completion date of May 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,624.62 firm fixed-price delivery order covers the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a period of performance through December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award, valued at $5,624.62, is for the supply of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract has a period of performance through April 19, 2023 and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating it was competitively awarded....
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJHW6Delivery Order
This federal contract award is a $5,624.62 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the delivery of Tasigna 200 mg capsules to be completed by March 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order was issued under the IDC and does not have a set-aside designation.
Generated 5/16/24, 10:18 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 2/15/24 |